Drugs / Donor microbiota
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02112279 | Apr 2014 → Jun 2015 | Clostridium difficile colitis | Providence Holy Cross Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02112279 ↗ |
| Modality | Other / unclassified | “Biological: Donor microbiota applied via colonoscopy.” NCT02112279 ↗ |
| Route | Other | “Stool mixture is administered into the terminal ileum and cecum through the biopsy channel of a colonoscope” NCT02112279 ↗ |